This was 5 months ago
LocationOnline
ProgrammesRICH Europe in collaboration with HNN3.0, Greenet and CARE4BIO invite you to a webinar on Transnational and Virtual Access Opportunities (TA/VA) to research infrastructure in Life Science, Circular Economy, Electronics and Earth Science.
Get to know the following projects during the webinar:
- AI4Life - Brings together the computational and life science communities
- ReMade@ARI - Recyclable Materials Development at Analytical Research Infrastructures
- RADNEXT - Emerging needs of electronics component and system irradiation
- EXCITE Network - Enhanced X(cross)-disciplinary Community-driven Imaging Technologies for Earth and Environmental
Presentations on these projects are followed by a Q&A session.
This webinar can be accessed via the following link (Teams Virtual Room). No prior registration is required.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.